Jon Flint

Founding Partner

Gregg Rubin

General Partner

4 past transactions

Amylyx Pharmaceuticals

Series C in 2021
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.

Sesame

Series B in 2021
Sesame is an award-winning company that offers Americans quality, convenient health care at half the typical price. The company's AI-enabled marketplace eliminates insurance, allowing healthcare providers to compete on quality, accessibility – and pricing. It is the official telehealth partner of Costco.

Akouos

Series B in 2020
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Frequency Therapeutics

Series C in 2019
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.